CARE vs SMBC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CARE

53.2
AI Score
VS
CARE Wins

SMBC

44.3
AI Score

Investment Advisor Scores

CARE

53score
Recommendation
HOLD

SMBC

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CARE SMBC Winner
Net Income 31.36M 19.10M CARE
ROE 7.5% 3.2% CARE
ROA 0.6% 0.4% CARE
Total Assets 4.85B 5.31B SMBC
Cash 105.16M 97.13M CARE
Free Cash Flow 31.81M 19.61M CARE

Relative Price Performance (Last 90 Days)

CARE 1M: -2.7% · 3M: -8.8% SMBC 1M: +1.5% · 3M: -7.7%

Current Technical Phase

CARE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 46

RSI (14): 46.3 · Price: $29.48

SMBC

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.5%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $71.49

Fundamentals Snapshot

Metric CARE SMBC
Market Cap — —
Forward P/E 11.8 10.9
Trailing P/E 5.0 10.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.2% 0.5%
EPS 5.91 6.78
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.